Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P49902 (5NTC_HUMAN) Homo sapiens (Human)

Cytosolic purine 5'-nucleotidase UniProtKBInterProSTRINGInteractive Modelling

561 aa; Sequence (Fasta) ; (Isoform 2); 14 identical sequences

Available Structures

43 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the double mutant (R39Q/D52N) of the full-length NT5C2 in the basal statehomo-4-mer24-553
PO4;EDO;
Assess
Crystal structure of the single mutant (D52N) of the full-length NT5C2 in the basal statehomo-4-mer24-553
PO4;
Assess
Crystal structure of the double mutant (D52N/R367Q) of the full-length NT5C2 in the basal statehomo-4-mer24-550
PO4;
Assess
Human cytosolic 5'-nucleotidase II soaked with 10mM 3-Phenyl-N-(9H-purin-6-yl)benzamidehomo-4-mer2-489
20×SO4;MG; 16×GOL;
Assess
Human cytosolic 5'-nucleotidase II soaked with 5mM3-Phenyl-N-(9H-purin-6-yl)benzamidehomo-4-mer3-489
MG; 12×SO4; 28×GOL;
Assess
Crystal structure of enzyme in purine metabolismhomo-4-mer3-488
48×GOL;
Assess
Crystal structure of D52N/R238W cN-II mutant bound to dATP and free phosphatehomo-4-mer3-488
PO4;MG;DTP; 16×GOL;
Assess
Crystal structure of S408R cN-II mutanthomo-4-mer3-488
12×GOL;MG;BR;
Assess
Crystal structure of D52N/R367Q cN-II mutant bound to dATP and free phosphatehomo-4-mer3-488
36×GOL;PO4;MG;DTP;
Assess
Crystal structure of R39Q cN-II mutanthomo-4-mer3-488
24×GOL;
Assess
Crystal structure of enzyme in purine metabolismhomo-4-mer3-488
28×GOL;
Assess
Crystal structure of K25E cN-II mutanthomo-4-mer3-488
36×GOL;MG;
Assess
Crystal structure of the double mutant (D52N/K359Q) of NT5C2-537X in the active state, Northeast St…homo-4-mer3-488
PO4;GOL;
Assess
Crystal structure of enzyme in purine metabolismhomo-4-mer3-488
52×GOL;
Assess
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inosine monop…homo-4-mer3-488
ATP;IMP; 24×GOL;MG;
Assess
Crystal structure of the double mutant (D52N/R238W) of NT5C2-537X in the active state, Northeast St…homo-4-mer3-488
ATP;MG;PO4;GOL;
Assess
Crystal structure of the double mutant (D52N/D407A) of NT5C2-537X in the active statehomo-4-mer3-488
16×PO4;GOL;
Assess
Crystal structure of R238G cN-II mutanthomo-4-mer3-488
28×GOL;MG;
Assess
Crystal structure of the single mutant (D52N) of NT5C2-Q523X in the active statehomo-4-mer3-488
16×PO4;GOL;
Assess
Crystal structure of the double mutant (D52N/L375F) of the full-length NT5C2 in the active statehomo-4-mer3-488
ATP;MG;PO4; 12×EDO;
Assess
Human cytosolic 5'-nucleotidase II soaked with 10mM 7-Benzyloxymethyl-7H-adeninehomo-4-mer3-488
24×SO4;GOL;MG;
Assess
Crystal structure of the apoform of the D52N variant of cytosolic 5'- nucleotidase IIhomo-4-mer3-488
16×GOL;
Assess
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inosine monop…homo-4-mer3-488
DG2;GOL;IMP;MG;
Assess
Crystal structure of the double mutant (D52N/R367Q) of NT5C2-537X in the active state, Northeast St…homo-4-mer3-488
IMP;
Assess
Human cytosolic 5'-nucleotidase II in complex with Anthraquinone-2,6- disulfonic acidhomo-4-mer3-488
11H;GOL;MG; 20×SO4;
Assess
Crystal structure of the double mutant (D52N/L375F) of NT5C2-537X in the active state, Northeast St…homo-4-mer3-488
PO4;
Assess
Crystal structure of the double mutant (R39Q/D52N) of the full-length NT5C2 in the active statehomo-4-mer3-488
PO4;ATP;MG;
Assess
Crystal structure of the single mutant (D52N) of the full-length NT5C2 in the active statehomo-4-mer4-488
16×PO4;GOL;
Assess
Crystal structure of the single mutant (D52N) of NT5C2-Q523X in the basal statehomo-4-mer25-508
PO4;
Assess
Crystal structure of the single mutant (D52N) of NT5C2-537X in the basal state, Northeast Structura…homo-4-mer25-507
MG;PO4;
Assess
Human cytosolic 5'-nucleotidase II in complex with 3-(3-Imidazol-1-ylphenyl)-N-(9H-purin-6-yl)benza…homo-4-mer26-493
GOL; 22×SO4;MG;53O;
Assess
Human cytosolic 5'-nucleotidase II in complex with N-(9H-Purin-6-yl)-3-(3-pyrrol-1-ylphenyl)benzami…homo-4-mer26-493
5WO; 20×ACT; 10×PO4;MG; 22×GOL;
Assess
Crystal structure of the double mutant (D52N/R367Q) of NT5C2-537X in the basal state, Northeast Str…homo-4-mer26-492
MN;PO4;
Assess
Crystal structure of Human Cytosolic 5'-Nucleotidase II in complex with adenosinehomo-2-mer3-488
GOL;MG; 10×SO4;ADN;
Assess
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inorganic pho…homo-2-mer3-488
ATP; 12×GOL;PO4;MG;
Assess
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with guanosine mon…homo-2-mer3-488
5GP;B4P; 16×GOL;MG;
Assess
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II with a covalently modified As…homo-2-mer3-488
DG2;GOL;
Assess
Crystal structure of Human Cytosolic 5'-Nucleotidase II in complex with beryllium trifluoridehomo-2-mer3-488
UNX;MG;SO4;
Assess
Crystal structure of Human Cytosolic 5'-Nucleotidase II (NT5C2, cN-II)homo-2-mer3-488
GOL; 12×SO4;MG;
Assess
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with deoxyguanosin…homo-2-mer3-488
GOL;DTP;DG;MG;
Assess
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with uridine 5'-mo…homo-2-mer3-488
U5P;ATP;GOL;MG;
Assess
Human cytosolic 5'-nucleotidase II co-crystallized with 10mM Sodium ((4-(3'-((7H-purin-6-yl)carbamo…monomer3-488
SO4;MG;GOL;
Assess
Human cytosolic 5'-nucleotidase II soaked with 10mM 2-(6-([1,1'-Biphenyl]-3-carboxamido)-9H-purin-9…monomer3-488
SO4;GOL;MG;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6de2.1.Dhomo-4-mer0.903-488
ATP;99.64
Assess
6ddq.1.Chomo-4-mer0.8324-553
99.64
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26ddq.1.Chomo-4-mer0.842-524
98.87
Assess